AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 66 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,293,443 | +12.3% | 1,733,391 | +26.5% | 0.03% | -3.4% |
| Q3 2022 | $2,933,000 | -24.1% | 1,370,757 | +0.4% | 0.03% | -23.7% |
| Q2 2022 | $3,864,000 | -32.6% | 1,365,429 | -0.7% | 0.04% | -19.1% |
| Q1 2022 | $5,734,000 | -23.5% | 1,375,106 | -4.8% | 0.05% | -21.7% |
| Q4 2021 | $7,499,000 | -18.7% | 1,444,802 | +2.6% | 0.06% | -21.1% |
| Q3 2021 | $9,225,000 | +100.5% | 1,408,317 | +164.1% | 0.08% | +81.0% |
| Q2 2021 | $4,602,000 | +338.7% | 533,250 | +338.7% | 0.04% | +320.0% |
| Q1 2021 | $1,049,000 | +133.1% | 121,565 | +141.4% | 0.01% | +100.0% |
| Q4 2020 | $450,000 | – | 50,354 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |